These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 6145363)

  • 1. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment.
    Fontaine R; Chouinard G; Annable L
    Am J Psychiatry; 1984 Jul; 141(7):848-52. PubMed ID: 6145363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.
    Rickels K; Schweizer E; Case WG; Greenblatt DJ
    Arch Gen Psychiatry; 1990 Oct; 47(10):899-907. PubMed ID: 2222129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
    Noyes R; Garvey MJ; Cook B; Suelzer M
    Am J Psychiatry; 1991 Apr; 148(4):517-23. PubMed ID: 2006699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clorazepate and lorazepam: clinical improvement and rebound anxiety.
    Rickels K; Fox IL; Greenblatt DJ; Sandler KR; Schless A
    Am J Psychiatry; 1988 Mar; 145(3):312-7. PubMed ID: 2894175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of withdrawal of buspirone and diazepam: a placebo controlled study.
    Fontaine R; Beaudry P; Beauclair L; Chouinard G
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):189-97. PubMed ID: 2888159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R; Annable L; Chouinard G; Ogilvie RI
    J Clin Psychopharmacol; 1983 Apr; 3(2):80-7. PubMed ID: 6132936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis.
    Lapierre YD; Tremblay A; Gagnon A; Monpremier P; Berliss H; Oyewumi LK
    J Clin Psychiatry; 1982 Sep; 43(9):372-4. PubMed ID: 6126475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence.
    Murphy SM; Tyrer P
    Br J Psychiatry; 1991 Apr; 158():511-6. PubMed ID: 1675901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety.
    Jacobson AF; Goldstein BJ; Dominguez RA; Steinbook RM
    J Clin Psychiatry; 1983 Aug; 44(8):296-300. PubMed ID: 6135690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal responses to abrupt discontinuation of desmethyldiazepam.
    Winokur A; Rickels K
    Am J Psychiatry; 1984 Nov; 141(11):1427-9. PubMed ID: 6437255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of mood states changes during and after 5 weeks of nightly triazolam administration.
    Bliwise DL; Seidel WF; Cohen SA; Bliwise NG; Dement WC
    J Clin Psychiatry; 1988 Sep; 49(9):349-55. PubMed ID: 3047100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome.
    Lemoine P; Kermadi I; Garcia-Acosta S; Garay RP; Dib M
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):131-7. PubMed ID: 16243418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benzodiazepine withdrawal syndrome in low dose dependency].
    Thomas H; Mörchen G
    Psychiatr Prax; 1996 Sep; 23(5):249-50. PubMed ID: 8992523
    [No Abstract]   [Full Text] [Related]  

  • 15. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study of efficacy and withdrawal.
    Fontaine R; Chouinard G; Annable L
    Psychopharmacol Bull; 1984; 20(1):126-7. PubMed ID: 6144130
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone.
    Rickels K; Schweizer E; Csanalosi I; Case WG; Chung H
    Arch Gen Psychiatry; 1988 May; 45(5):444-50. PubMed ID: 2895993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buspirone: multicenter efficacy study.
    Wheatley D
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.